Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer Tissue.

about

MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer.

P2860

Q55347158-ED9CC293-BD0C-4707-8392-AB0E3FDCCB1C

P2860

Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer Tissue.

Item

http://www.wikidata.org/entity/Q38656185

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Automated Image Analysis of HE ...... neity in Breast Cancer Tissue.

@en

type

Item

label

Automated Image Analysis of HE ...... neity in Breast Cancer Tissue.

@en

prefLabel

Automated Image Analysis of HE ...... neity in Breast Cancer Tissue.

@en

P1476

Automated Image Analysis of HE ...... neity in Breast Cancer Tissue.

@en

P2093

Aida Laurinaviciene

http://www.w3.org/2001/XMLSchema#string

Allan Rasmusson

http://www.w3.org/2001/XMLSchema#string

Daiva Lesciute-Krilaviciene

http://www.w3.org/2001/XMLSchema#string

Eduard Clim

http://www.w3.org/2001/XMLSchema#string

Gedmante Radziuviene

http://www.w3.org/2001/XMLSchema#string

P2860

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.

HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event

Breast cancer evaluation by fluorescent dot detection using combined mathematical morphology and multifractal techniques

HER2: biology, detection, and clinical implications

Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system.

Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Trastuzumab as adjuvant therapy for early breast cancer: the importance of accurate human epidermal growth factor receptor 2 testing.

P304

2321916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/2321916

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Arvydas Laurinavicius

Renaldas Augulis

P577

2017-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28752092

http://www.w3.org/2001/XMLSchema#string

P921

automation

P932

5511668

http://www.w3.org/2001/XMLSchema#string

Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer Tissue.

about

P2860

P2860

Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer Tissue.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932